🔍 Observations
Topline
- Revenue from operations nearly doubled YoY — ₹14,445 Cr in FY25 to ₹26,537 Cr in FY26 (+83.7%), driven overwhelmingly by Solar PV Modules (₹12,957 Cr → ₹24,133 Cr, +86.2%).
- Q4FY26 revenue hit ₹8,480 Cr — up 111.8% YoY vs Q4FY25’s ₹4,004 Cr — signalling accelerating momentum into year-end.
- EPC segment nearly doubled too (₹1,559 Cr → ₹3,282 Cr, +110.5%), emerging as a meaningful second growth engine alongside modules.
Bottomline
- PAT grew from ₹1,928 Cr to ₹3,884 Cr (+101.4% YoY) — profit growth outpaced revenue growth, a hallmark of operating leverage kicking in.
- Attributable PAT (to parent) grew from ₹1,869 Cr to ₹3,709 Cr (+98.5%); NCI profit jumped from ₹61 Cr to ₹173 Cr, reflecting subsidiary scale-up.
- Basic EPS nearly doubled: ₹68.24 → ₹129.10 (+89.2%), with no meaningful equity dilution.
Margins
- EBIT (pre-unallocable): ₹4,981 Cr on ₹26,537 Cr revenue = 18.8% EBIT margin vs ₹2,361 Cr on ₹14,445 Cr = 16.3% in FY25 — 250 bps expansion.
- EBITDA (EBIT + D&A of ₹990 Cr) = ₹5,971 Cr → 22.5% EBITDA margin vs (₹2,361 + ₹402 Cr) = ₹2,763 Cr → 19.1% in FY25 — ~340 bps improvement.
- Net margin: ₹3,884 Cr ÷ ₹26,537 Cr = 14.6% vs ₹1,928 Cr ÷ ₹14,445 Cr = 13.3% in FY25 — clean bottom-line margin expansion alongside revenue scale.
Growth Trajectory
- FY26 revenue of ₹26,537 Cr and Q4FY26 run-rate of ₹8,480 Cr implies an annualised pace exceeding ₹33,000 Cr — growth is not plateauing.
- D&A nearly tripled (₹402 Cr → ₹990 Cr), reflecting aggressive capacity additions — the investment cycle is deep and ongoing.
- Module EBIT margin: ₹4,423 Cr on ₹24,133 Cr = 18.3% vs ₹2,065 Cr on ₹12,957 Cr = 15.9% in FY25 — operational efficiency improving even at higher volume.

🧮 Profit & Loss Statement

🧮 Balance Sheet

🧮 Cash Flows Statement

🟢 Green Flags
- 83.7% revenue growth with 101.4% PAT growth — operating leverage is real; incremental margins are expanding faster than topline.
- EPC segment EBIT doubled (₹273 Cr → ₹548 Cr) on 110% revenue growth — both segments firing simultaneously, reducing concentration risk.
- Module EBIT margin expanded 240 bps to 18.3% — scale benefits accruing even in a commoditising segment.
- PPE + CWIP grew from ₹5,444 Cr to ₹9,523 Cr — capacity infrastructure nearly doubled, underpinning future revenue growth.
- Equity base nearly doubled (₹9,595 Cr → ₹15,011 Cr) via retained earnings — self-funded growth with minimal equity dilution.
- Net debt remains modest: Total borrowings = ₹2,491 Cr (₹815 + ₹1,676 Cr) vs equity of ₹15,011 Cr — Debt/Equity = 0.17x; balance sheet is largely unlevered.
- Other equity grew ₹4,958 Cr (₹9,192 Cr → ₹14,150 Cr) — driven by retained profits, not capital raises; quality of equity accretion is high.
🔴 Red Flags
- OCF collapsed: FY26 operating cash flow = ₹1,627 Cr vs ₹3,158 Cr in FY25 — PAT doubled but OCF halved, driven by massive working capital build.
- Inventory surge: ₹2,692 Cr → ₹5,856 Cr (+117%) — ₹3,164 Cr cash consumed; if offtake slows, this is a significant liquidation risk.
- Trade receivables nearly tripled: ₹1,053 Cr → ₹2,492 Cr (+136%) — revenue growth partly credit-funded; collection quality must be watched.
- Exceptional item in Q3FY26: ₹294.78 Cr charge — nature undisclosed in the data; one-off but material (~5.8% of reported PBT).
- Capex intensity is high: ₹4,882 Cr PPE additions in FY26 alone — free cash flow (OCF − Capex) = ₹1,627 − ₹4,882 Cr = negative ₹3,255 Cr; company is a net cash consumer.
- Finance costs nearly doubled (₹152 Cr → ₹281 Cr) — borrowings rising; interest coverage = EBIT ₹4,981 Cr ÷ ₹281 Cr = 17.7x (comfortable, but trend bears watching).
- Other current liabilities at ₹5,632 Cr (up from ₹4,600 Cr) — largely advance receipts, but creates execution obligations that must be discharged.
📊 Balance Sheet Analysis
- Asset base nearly doubled (₹19,485 Cr → ₹30,115 Cr) — driven by PPE, CWIP, and inventory; growth is asset-heavy and capex-intensive.
- Liquidity is sound: Cash + bank balances = ₹774 Cr + ₹5,954 Cr = ₹6,728 Cr; current ratio = ₹17,577 Cr ÷ ₹12,708 Cr = 1.38x — adequate cover.
- Leverage is low: Net debt (borrowings ₹2,491 Cr less cash ₹6,728 Cr) = net cash positive of ~₹4,237 Cr — the company is net cash despite heavy capex.
- CWIP of ₹3,476 Cr indicates significant capacity under commissioning — execution risk exists until these assets turn productive.
💰 Cash Flow Analysis
- OCF of ₹1,627 Cr is misleading at face value — underlying operating profit was strong (₹5,916 Cr pre-WC), but a ₹4,289 Cr working capital outflow (inventory + receivables) absorbed most of it.
- Investing outflow: ₹3,953 Cr — capex of ₹4,882 Cr partially offset by FD maturities and investment proceeds; the company is in a heavy reinvestment phase.
- Financing inflow: ₹2,573 Cr — net new borrowings of ₹1,552 Cr and subsidiary equity proceeds of ₹1,540 Cr bridged the free cash flow deficit.
- FD book (₹5,954 Cr in bank balances) provides a liquidity buffer, but continued negative FCF makes external funding dependence structurally necessary until capex moderates.
💡 Investment Outlook
Waaree has delivered a landmark FY26 — revenue and profit both effectively doubled, with margin expansion, low leverage, and a dominant market position in Indian solar manufacturing.
The core business is compounding well. The primary concern is working capital intensity: inventory and receivables growth are consuming cash faster than profits generate it, and free cash flow is deeply negative.
Investors should track WC cycle normalisation and CWIP commissioning milestones closely — resolution of these two variables will determine whether FY27 sees the balance sheet quality catch up to the P&L quality.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial spreadsheets, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.